Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Nov;17(11):2035-7.
doi: 10.3201/eid1711.110291.

International spread of MDR TB from Tugela Ferry, South Africa

Affiliations
Case Reports

International spread of MDR TB from Tugela Ferry, South Africa

Graham S Cooke et al. Emerg Infect Dis. 2011 Nov.

Abstract

We describe a death associated with multidrug-resistant tuberculosis and HIV infection outside Africa that can be linked to Tugela Ferry (KwaZulu-Natal, South Africa), the town most closely associated with the regional epidemic of drug-resistant tuberculosis. This case underscores the international relevance of this regional epidemic, particularly among health care workers.

PubMed Disclaimer

Figures

Figure
Figure
Retinal image from patient with evidence of choroidal tuberculosis.

References

    1. Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375:1830–43. 10.1016/S0140-6736(10)60410-2 - DOI - PubMed
    1. O’Donnell MR, Jarand J, Loveday M, Padayatchi N, Zelnick J, Werner L, et al. High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers. Ann Intern Med. 2010;153:516–22. - PMC - PubMed
    1. Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, et al. HIV coinfection in multidrug- and extensively drug–resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med. 2010;181:80–6. 10.1164/rccm.200907-0989OC - DOI - PubMed
    1. Moghazeh SL, Pan X, Arain T, Stover CK, Musser JM, Kreiswirth BN. Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. Antimicrob Agents Chemother. 1996;40:2655–7. - PMC - PubMed
    1. Ma X, Wang H, Deng Y, Liu Z, Xu Y, Pan X, et al. rpoB Gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China. J Clin Microbiol. 2006;44:3409–12. 10.1128/JCM.00515-06 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources